Do GLP-1 Drops Work? What the Evidence Says (October 2026)

01 · The core answer

Do GLP-1 drops work? The short, honest answer

The trial evidence for licensed GLP-1 medicines says nothing about sublingual or oral drops, tinctures or sprays sold as supplements. When a seller says its drops "work like Mounjaro" or "work like Ozempic", the claim borrows the credibility of a different product.

It helps to separate three things that get blended together in marketing. First, GLP-1 is a natural gut hormone, and licensed medicines activate its receptor. Second, a licensed medicine has been through trials, has a product licence, an official leaflet, a known side-effect profile and a prescriber who checks whether it suits you. Third, a supplement drop is a consumer product. It may borrow the name GLP-1, but the name on a bottle is not evidence that the contents behave like a medicine.

So the question "do they work?" really splits into two. Do drops produce the kind of weight loss seen in the tirzepatide trials? Could they do harm? Any product taken with no clinical oversight carries risks, especially if it is combined with prescription medicines or bought from a seller you cannot verify. If you want a deeper look at the product type itself, our guide to drops for weight loss goes through the claims one by one.

02 · What the evidence supports

What the evidence does support

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

That is the benchmark any product should be held to. A treatment worth taking can tell you its trial name, its dose, its duration, who it was tested on and what the side effects were.

03 · What to do next

The decision you are actually facing

If injections are the sticking point, talk it through with a prescriber, because some people find the pen easier than they expected. If cost is the issue, the live price is shown on the Mounjaro pen page: your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price.

If you are not sure whether you are eligible, the free consultation is a no-obligation way to find out; it is reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically. Our weight loss clinic page explains the whole route in more detail. If you are only curious about the topic, the related guides on oral drops and on the common claims made for drops go deeper into specific questions.

04 · What GLP-1 actually is

What GLP-1 actually is and why the name gets borrowed

GLP-1 is the name of a natural gut hormone, and the receptor it acts on is the target of several licensed medicines. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

That is the reason "GLP-1" has become a marketing term. Because the hormone is natural, sellers can say a product "supports natural GLP-1" or is "GLP-1 inspired" without making any claim that would need to be proven. The phrase suggests a connection to prescription medicines such as Mounjaro and Wegovy while saying nothing testable about what is in the bottle or what it does in your body.

It is worth being precise about what a medicine is. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen, the KwikPen, in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Every part of that sentence can be checked against the official product information: the active ingredient, the strengths, the route, the licensed uses.

Now compare that with a typical drops listing. The ingredient list may name plant extracts or amino acids. The label may promise to "boost" or "activate" GLP-1. But a statement that a product supports a hormone is not a licensed indication, and it is not the same as a drug that binds to the hormone's receptor in a measured, studied way.

The practical point for you as a reader: the word GLP-1 on a label tells you very little. Ask what the product is legally classified as, whether it has a UK licence, who prescribes it, and which trial it was tested in. If the honest answers are "a supplement", "no", "nobody" and "none", then the results of trials on licensed medicines are simply not about that product.

If you want to see how this plays out for a specific ingredient, our page on moringa products takes one popular example and applies the same test, and our overview of GLP-1 drops collects the main product types in one place.

05 · How real treatment works

How licensed GLP-1 treatment works in practice

Licensed treatment works by acting on appetite and digestion, not by a single "activation" trick. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That is the whole role of the medicine: it makes the diet easier to follow. It does not replace the diet, and the trial results depend on both being in place.

Tirzepatide is given once weekly by injection with a pre-filled pen. The dose starts low at 2.5mg and rises through 5mg, 7.5mg, 10mg and 12.5mg up to 15mg, with the prescriber deciding how far you go. This is a medical process with checkpoints, which is exactly what is missing when a product is simply posted out as a supplement.

Why does the injection route matter? The licensed product was designed, dosed and tested as an injection, and the trial results belong to that product at those doses. Changing the form, the dose or the ingredient creates a different product with a different, unknown profile. That is why trial figures cannot be borrowed across formats.

There is also the question of how long the medicine stays in the body. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ That is a measured, documented property of a specific medicine. A supplement drop comes with no equivalent information about how long it acts, how it is absorbed or what it interacts with.

It is also why a prescriber's input matters. Before treatment is supplied, a GPhC-registered prescriber reviews your answers. Afterwards, ongoing monthly reviews cover dose, side effects and progress. If you are curious about the newer needle-free prescription options, our blog explains how Foundayo works; it is a licensed tablet, which is very different from a supplement drop, and it too is only available on prescription.

The takeaway is simple. "Needle-free" is not the same as "unlicensed". Some prescription GLP-1 treatments are tablets, and they have been through the same licensing process as the injections. A drop sold without a prescription has not.

06 · What trials show

What the trials show, and what they do not

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

A worked example makes the average easier to picture. For someone starting at 100 kg, 20.9% is about 21 kg. That is an average from a trial population on the top dose, not a forecast for any individual, and the results depend on staying on treatment and following the diet and activity advice.

Now think about what a fair comparison would require. To say a drop works as well as an injection, you would want a trial that tested that drop, named its dose, ran for a defined period and reported weight change against a comparison group. Without a trial like that, there is no evidence that a drop works. It means any figure you see in a drops advert is either borrowed from the licensed medicines or unsupported.

Be especially wary of the following patterns: a trial name quoted for a different product; percentages with no named study; before-and-after photos; and claims of results in a handful of days. Treat dramatic weight-loss claims as marketing unless a named, checkable trial of that exact product stands behind them.

It is also worth knowing what trials do not tell you. They report averages, and averages hide a wide range. Trial averages do not predict your own result. The strongest message from the evidence is that real weight loss on licensed treatment is gradual, dose-dependent, and bound up with changes in eating and activity. If someone promises more, faster or effortlessly, the burden of proof is on them.

07 · Realistic pace

What realistic progress looks like

Weight loss on licensed treatment is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.² Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.

This matters when you are weighing up any product that promises something faster. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. In SURMOUNT-1, average weight loss built month by month, with the full 15–21% averages measured at 72 weeks, not 12. A sensible expectation at this stage on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.

Slower early progress does not predict failure, because the dose you respond to may still be ahead of you. In the same way, rapid early loss is not proof that something is working: early loss includes water weight, so the trend over weeks matters more than any single weigh-in.

Some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.

Plateaus are part of the picture too. Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight. Within the licence, the responses are to review food intake honestly, because portions drift back up; protect protein and activity; check the basics such as sleep and alcohol; and discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.

People who plateau, or who feel the medicine is too slow, are the audience for products promising an "extra boost". Take the plateau to your prescriber instead. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.

Our companion article on tirzepatide drops covers a related claim, where the active ingredient's name is borrowed for a product that is not the licensed medicine.

08 · Safety and red flags

Safety, scams and red flags

The biggest risk with GLP-1 drops is not a dramatic side effect but a lack of oversight. A product bought online outside a regulated pharmacy comes with no consultation, no check on your other medicines and no one to contact if something goes wrong. Counterfeit medicine alerts and the Yellow Card scheme are both run by the MHRA, and they exist because unregulated products do circulate.⁷

Use this checklist when you see a GLP-1 product for sale:

• Does the seller offer to supply without a consultation or prescription? For a prescription medicine, that is a warning sign.
• Does the page promise specific results or dramatic weight-loss claims? Real treatment cannot.
• Is the dosing vague or non-standard? Dosing is not standardised for supplements.
• Can you check the seller on a public register? A UK pharmacy appears on the GPhC register; ours is GPhC 9012878.¹²
• Is the product described as a medicine in one place and a supplement in another? That mismatch is often how sellers avoid regulation.

There is also the matter of combining products. A prescriber needs to know everything you take.

If you take a product and feel unwell, stop, speak to a pharmacist or doctor and consider reporting it. Side effects of medicines and suspected problems with other products can be reported through the MHRA Yellow Card scheme.¹⁹

Finally, a note on the "natural" label. Natural does not mean safe or effective, and it does not mean tested. It is a description, not a safety standard. A low-cost supplement with no clinical oversight is not made safer by being plant-based, and it is not made effective by naming a hormone.

The prescription question is covered in our related guide, which explains why no legitimate route turns a supplement into a prescription medicine.

09 · NHS and private routes

NHS and private routes to genuine treatment

If you want proven GLP-1 treatment, there are two legitimate routes: the NHS and regulated private care. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

That is the honest picture. If you are in a higher-need group, speak to your GP about NHS access. If you do not yet qualify, or do not want to wait, private treatment through a registered pharmacy is the alternative, and the key word is registered. A GPhC-registered pharmacy dispenses prescription medicines only after a prescriber has reviewed your consultation. Check the register, and treat any seller that skips this step as a seller to avoid.

Our service works like this. You complete a free online consultation, a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews it, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Approved orders are dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm, and delivered by free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99. Mounjaro is supplied via official LillyDirect supply, direct from Eli Lilly's UK distribution.

On cost, we show prices openly. Every dose is in stock. Across the UK pharmacies we track, the cheapest and dearest Mounjaro pens range from £143.96 to £339.00 per month, as checked 10 October 2026.

For planning, if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. Separately, a first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, before discounts. A new customer's first order is £40 less and every later order £25 less. You can look at the live prices on the Mounjaro product page.

Payment options include Visa, Mastercard, Klarna and pay-monthly options, with no subscriptions. Repeat orders re-check suitability, and there is no auto-shipping.

10 · Injection alternatives

Needle-free and other prescription alternatives

If the reason you are looking at drops is a dislike of needles, it is worth knowing that licensed alternatives exist, and they are prescription medicines. Wegovy tablets, which are oral semaglutide, and Foundayo, which is orforglipron, are both licensed tablets with official product information.²⁰²¹ They have their own trials, OASIS 4 and ATTAIN-1 respectively.²²²³ Their trial results are not compared with Mounjaro's as if they were head to head; see the current Wegovy tablet prices on the product page.

Wegovy itself is a once-weekly injection of semaglutide. The pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, and titration steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17. The 2.4mg dose is the licensed maintenance dose for weight management.¹⁸ You can read more on the Wegovy pen page, and check availability at the time of order.

Liraglutide, sold as Saxenda and in products such as Erly, is a daily injection at a concentration of 6mg per millilitre, unlike once-weekly Mounjaro and Wegovy. Your prescriber can advise on liraglutide.

The comparison that matters is between medicines, not between a medicine and a supplement. If you are deciding between licensed options, a prescriber is the right person to help weigh suitability, preference, tolerance and cost.

Beyond the scales, trials of tirzepatide also reported average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises, but they are why prescribers talk about weight management as health management rather than appearance. A drop with no clinical oversight offers no way to monitor any of this.

If you are not ready for any medicine, that is a legitimate choice too. Reduced-calorie eating, more activity, sleep and alcohol review remain the foundation, and licensed treatment is used alongside them. Our weight loss clinic explains how to start the conversation without any commitment.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹ Mounjaro can reduce how well oral contraceptive pills are absorbed. Switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.